Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

Sebocytes play a key role in controlling androgen levels in human skin.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

PRP injections help regrow hair, reduce hair loss, and increase hair thickness, but effects decrease without ongoing treatment.

Men taking 5-alpha-reductase inhibitors before or after bladder cancer diagnosis had a lower risk of dying from the disease.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Rosiglitazone may be better than metformin for insulin resistance in PCOS, but more research is needed on certain biomarkers.

About 19.4% of Iranian women in the study have Polycystic Ovary Syndrome, with the most common type involving irregular periods and high male hormone levels, but their heart and metabolic health is similar to women without the condition.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Finasteride increases risk of depression, possibly suicidal thoughts, and sexual dysfunction.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

No strong genetic link to other skin conditions was found, but some genetic factors may make people more likely to get seborrheic dermatitis.

Resistance training might help with PCOS symptoms, but more research is needed.

Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Dutasteride effectively treats hair loss in men who don't respond to finasteride.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

Tofacitinib shows promise for treating severe alopecia areata with good safety and effectiveness.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Platelet-Rich Plasma (PRP) treatment may increase hair growth for genetic hair loss, but more research is needed to confirm this.

Tailor treatments for vitiligo to patient needs for best results.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

The IRS-2 Asp/Asp genotype may increase the risk of PCOS in Chinese women, especially if they are not obese.